Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien

Susanne Rabady, Johann Altenberger, Markus Brose, Doris-Maria Denk-Linnert, Elisabeth Fertl, Florian Götzinger, Maria de la Cruz Gomez Pellin, Benedikt Hofbaur, Kathryn Hoffmann, Renate Hoffmann-Dorninger, Rembert Koczulla, Oliver Lammel, Bernd Lamprecht, Judith Löffler-Ragg, Christian A Müller, Stefanie Poggenburg, Hans Rittmannsberger, Paul Sator, Volker Strenger, Karin VonbankJohannes Wancata, Thomas Weber, Jörg Weber, Günter Weiss, Maria Wendler, Ralf-Harun Zwick

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Artikel in Fachzeitschrift

19 Zitate (Scopus)

Abstract

This guideline comprises the state of science at the time of the editorial deadline. In view of the high turnover of knowledge the guideline is designed as a living guideline. The main objective was to provide a tool for the use in primary care, being considered well suited as a first point of entry and for the provision of care. The guideline gives recommendations on the differential diagnosis of symptoms following SARS-CoV‑2 infection, on their therapeutic options, as well as for guidance and care of the patients concerned. It also offers advice concerning return to daily life and rehabilitation. Long COVID being a very variable condition, we chose an interdisciplinary approach.

Titel in ÜbersetzungGuideline S1: Long COVID: Diagnostics and treatment strategies
OriginalspracheDeutsch
Seiten (von - bis)237-278
Seitenumfang42
FachzeitschriftWiener Klinische Wochenschrift
Jahrgang133
AusgabenummerSuppl 7
DOIs
PublikationsstatusVeröffentlicht - Dez. 2021

Schlagwörter

  • COVID-19/complications
  • Humans
  • SARS-CoV-2

Fingerprint

Untersuchen Sie die Forschungsthemen von „Leitlinie S1: Long COVID: Differenzialdiagnostik und Behandlungsstrategien“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren